Microchip Technology shipped more in its September quarter than it had forecast. Then, on 5 November, it told investors it could have shipped more still — if AI data-centre buyers had not filled its suppliers' factories.

"They came in and took over the whole factory. They pushed everybody out," CEO Steve Sanghi said of the AI companies. The shortage, he explained, is not in wafer starts but in factory capacity: data-centre buyers have taken packaging and test lines at outside assembly and test houses (OSATs), some substrates are simply unavailable, and trailing-edge capacity is tight. Standard products that used to arrive in four to eight weeks now take six to 32.

The market read it as a warning. Microchip shares fell 10.02% to $58.35 on Friday 6 November, after a 13.92% slide the day before in a sector-wide chip selloff. From the $75.34 close on 4 November, the stock is down 22.55%.

The numbers behind the drop

Net sales came in at $1.622 billion, above the top of guidance — up 9.2% quarter on quarter and 42.2% year on year. Non-GAAP EPS was $0.97, but GAAP EPS was $0.68, and that figure already included a 13-cent-per-share tax benefit.

About $53 million of the quarter was one-time revenue at 100% gross margin: a $21 million price change on distributor inventory, $22 million of extra patent licensing and $10 million from a customer contract. Those items lifted non-GAAP gross margin to 66.5%, which is why December guidance steps down rather than up. The company guided December net sales to $1.573–1.638 billion with gross margin of 64–65% — a midpoint still 35.4% above a year earlier.

How a lead time becomes lost revenue

Lead-time inflation does not just annoy customers; it changes when money is recognised. Orders placed inside the new window often go unfilled, so that revenue slides into a later quarter. Microchip's book-to-bill stayed well above one, and it entered the December quarter with more backlog than it had going into September. Moving the work in-house or to alternative suppliers takes about six months.

That is why Sanghi said "some deceleration of the AI demand actually would be quite positive early on" — a striking thing for a chipmaker to say in the middle of an AI boom.

Microchip is an AI beneficiary too, which sharpens the point. Its data-centre business topped $250 million in the quarter, grew 55.7% year on year and is tracking toward a $1 billion calendar-2026 run rate. The same demand that lifts that segment is squeezing the commodity lines the rest of its customers depend on. Then there is cost: Sanghi said most major foundries and OSATs will raise prices again from around January.

Why this one is bigger than one mid-cap

The AI buildout is usually told through HBM stacks and leading-edge nodes. But capacity is fungible at the seams: packaging and test lines, substrates, mature-node output. When a data-centre buyer books an OSAT's line, the shortage surfaces in a car's body controller, a washing machine's motor drive, a factory PLC — months later and thousands of miles away, in the form of a longer lead time and a price increase.

Analysts cut targets but kept them above Friday's close: Truist to $62 from $90, Raymond James to $80 from $125, Citi to $75 from $95, JPMorgan to $100 from $120. The test of whether this is a timing glitch or structural damage is the March-quarter guide: if the slipped backlog converts to revenue, the pressure was temporary. If it does not, the margin hit lasts longer than one quarter.

What to watch

- Whether lead times compress once the roughly six-month re-qualification completes, or keep extending as AI orders roll forward. - January foundry and OSAT price increases — and whether Microchip passes them through. - Whether other trailing-edge suppliers report the same crowding, which would make this an industry condition rather than one company's bad quarter.